Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of pure autonomic failure with a long-term-45-year-clinical course since the initial detection of abnormal blood pressure fluctuation.

Rinsho shinkeigaku = Clinical neurology·2026
Same author

The Agreement of Readability and Interpretability of Fetal Heart Rate Between Mobile and Conventional Cardio-Tocography.

Diagnostics (Basel, Switzerland)·2026
Same author

Persistent Interleukin-1β Elevation in Post-COVID-19 Patients: Findings From a Nationwide Registry Study in Japan.

Neuropsychopharmacology reports·2026
Same author

Poly(acrylamide/styrenesulfonic acid) hydrogels for effective removal of Cr(III) ions.

Scientific reports·2025
Same author

Examination of simple artificial intelligence-based analysis of dopamine transporter scintigraphy for supporting a diagnosis of Parkinson's disease.

Annals of nuclear medicine·2025
Same author

Electroconvection of a nematic liquid crystal in polymer networks as porous media.

Physical review. E·2025

Related Experiment Video

Updated: Jun 13, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

[PTCA].

Kazuhiro Hara1

  • 1Division of Cardiology, Mitsui Memorial Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 15, 2010
PubMed
Summary
This summary is machine-generated.

Primary percutaneous coronary intervention (PTCA) for heart attack significantly lowers risks of death, reinfarction, and stroke compared to fibrinolysis. Minimizing door-to-balloon time is crucial for better patient outcomes in acute myocardial infarction.

More Related Videos

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Related Experiment Videos

Last Updated: Jun 13, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Acute Coronary Syndromes

Context:

  • Primary percutaneous coronary intervention (PTCA) is a key treatment for acute myocardial infarction (AMI).
  • Fibrinolysis has been a comparator treatment for AMI, with varying outcomes.
  • Non-ST elevation acute coronary syndrome (NSTE-ACS) also presents challenges requiring intervention.

Purpose:

  • To evaluate the effectiveness of primary PTCA in reducing mortality, reinfarction, and stroke post-AMI.
  • To assess the impact of hospital delay on in-hospital mortality for primary PTCA.
  • To explore the role of PTCA in managing NSTE-ACS and associated ischemic complications.

Summary:

  • Primary PTCA demonstrated superior outcomes compared to fibrinolysis for AMI, reducing death, reinfarction, and stroke at discharge or 30 days.
  • In-hospital mortality increased significantly with longer door-to-balloon times, highlighting the need for rapid intervention.
  • While PTCA relieved chest pain and ischemia in NSTE-ACS, significant ischemic complications necessitated further medical stabilization and advancements like stents and antithrombotics.

Impact:

  • Establishes primary PTCA as a preferred reperfusion strategy for AMI, emphasizing time sensitivity.
  • Underscores the importance of reducing door-to-balloon times to improve survival rates.
  • Identifies limitations of early PTCA in NSTE-ACS and the subsequent need for improved adjunctive therapies and devices.